In vivo depletion of host CD4+ and CD8+ cells permits engraftment of bone marrow stem cells and tolerance induction with minimal conditioning

Surgery

Volumn 122, Issue 2, 1997, Pages 221-227

  Exner, Beate G ^b   Colson, Yolonda L ^b   Li, Hua ^b   Ildstad, Suzanne T ^a  

^a DREXEL UNIVERSITY COLLEGE OF MEDICINE   (United States)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

CD4 ANTIGEN; CD8 ANTIGEN;

ANIMAL CELL; BONE MARROW CELL; BONE MARROW TRANSPLANTATION; CELL TYPE; CHIMERA; CONFERENCE PAPER; GRAFT REJECTION; GRAFT SURVIVAL; IMMUNOLOGICAL TOLERANCE; IN VIVO STUDY; LYMPHOCYTE COUNT; MAJOR HISTOCOMPATIBILITY COMPLEX; MOUSE; NONHUMAN; ORGAN TRANSPLANTATION; PRIORITY JOURNAL; STEM CELL;

EID: 0030773071     PISSN: 00396060     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0039-6060(97)90012-X     Document Type: Conference Paper

References (28)

1. Dunn D. Problems related to immunosuppression: infection and malignancy occurring after solid organ transplantation. Crit Care Clin 1990;6:955-71.
2. Gao SZ, Schroeder J, Hunt S, Stinson E. Retransplantation for severe accelerated coronary disease in heart transplant recipients. Am J Cardiol 1988,62:876-81.
3. Owen RD. Immunogeneic consequences of vascular anastomosis between bovine twins. Science 1945;102:400-1.
4. Billingham RE, Lamphin HG, Medawar PB, et al. Tolerance of homografts, twin diagnostics and the freemartin condition in cattles. Heredity 1952;6:201-2.
5. Billingham RE, Brent L, Medawar PB. Actively acquired tolerance of foreign cells. Nature 1953;172:603-23.
6. Slavin S, Strober S, Fuks Z, Kaplan HS. Induction of specific tissue transplantation tolerance using fractionated total lymphoid irradiation in adult mice: long-term survival of allogeneic bone marrow and skin grafts. J Exp Med 1977;146:34-8.
7. Ildstad ST, Sachs DH. Reconstitution with syngeneic plus allogeneic or xenogeneic bone marrow leads to specific acceptance of allografts or xenografts. Nature 1984;307:168-9.
8. Rapaport FT, Bachvaroff RJ, Watanabe K, Hirsawa H, Cannon FD, Mollen N, et al. Immunologic tolerance: irradiation and bone marrow transplantation induction of canine allogeneic unresponsiveness. Transpl Proc 1977;9:891-4.
9. Thomas JM, Carver FM, Foil MB, et al. Renal allograft tolerance induced with ATG and donor bone marrow in outbred rhesus monkeys. Transplantation 1982;36:104-6.
10. Colson YL, Zadach K, Nalesnik M, Ildstad ST. Mixed allogeneic chimerism in the rat: donor-specific tolerance without chronic rejection for primarily vascularized cardiac allografts. Transplantation 1995;60:971-80.
11. Blom D, Morrissey NJ, Mesonero C, et al. Induction of specific tolerance through mixed hematopoietic chimerism prevents chronic renal allograft rejection in a rat model. Surgery 1996;120:213-20.
12. Orloff MS, Fallon MA, De Mara E, Coppage MI, Leong N, Cerilli J. Induction of specific tolerance to small-bowel allografts. Surgery 1994;116:222-8.
13. Sayegh MH, Fine NA, Smith JL, Rehnke HG, Milford EL, Tilney NL. Immunologic tolerance to renal allografts after bone marrow transplants from the same donors. Ann Intern Med 1991;114:954-5.
14. Wood M, Monaco A. Models of specific unresponsiveness to tissue allografts in anti-lymphocyte serum (ALS) treated mice. Transplant Proc 1978;10:379-80.
15. McCarthy SA, Griffith IJ, Gamble P, et al. Immunological competence and host-specific tolerance of antibody-facilitated bone marrow chimeras. Transplantation 1987;44:97-105.
16. Cobbold SP, Martin G, Qin S, et al. Monoclonal antibodies to promote marrow engraftment and tissue graft tolerance. Nature 1986;323:164-6.
17. Sharabi Y, Sachs DH. Mixed chimerism and permanent specific transplantation tolerance induced by a nonlethal preparative regimen. J Exp Med 1989;169:493-502.
18. Mayumi H, Good RA. The necessity of both allogeneic antigens and stem cells for cyclophosphamide-induced skin allograft tolerance in mice. Immunobiology 1989;178:287-304.
19. Colson YL, Wren SM, Schuchert MJ, et al. A nonlethal conditioning approach to achieve durable multilineage mixed chimerism and tolerance across major, minor and hematopoietic histocompatibility barriers. J Immunol 1995;155:4179-88.
20. Colson YL, Li H, Boggs Sallie SS, Partrene KD, Johnson PC, Ildstad ST. Durable mixed allogeneic chimerism and tolerance by a non-lethal radiation-based cytoreductive approach. J Immunol 1996;157:2820-9.
21. Forsythe JLR. ATG - a polyclonal sledgehammer? Transpl Immunol 1994;2:148-52.
22. Down JD, Tarbell NJ, Thames HD, Mauch PM. Syngeneic and allogeneic bone marrow engraftment after total body irradiation: dependence on dose, dose rate, and fractionation. Blood 1991;7:661-9.
23. Tomita Y, Sachs DH, Sykes M. Myelosuppressive conditioning is required to achieve engraftment of pluripotent stem cells contained in moderate doses of syngeneic bone marrow. Blood 1994;83:939-48.
24. Exner BG, Kaufman CL, Ildstad ST. Engraftment of physiologic numbers of bone marrow cells in syngeneic recipients with minimal irradiation (11 cGy). Poster presentation at the Fourth International Conference on Tolerance Induction, Breckenridge (CO), Jan. 19-22, 1997.
25. Brecher G, Ansell JD, Micklem HS, Tjio J-H, Cronkite EP. Special proliferative sites are not needed for seeding and poliferation of transfused bone marrow cells in normal syngeneic mice. Proc Natl Acad Sci USA 1982;79:5085-7.
26. Stewart FM, Crittenden RB, Lowry PA, Pearson-White S, Quesenberry PJ. Long-term engraftment of normal and post-5-fluorouracil murine marrow into normal nonmyeloablated mice. Blood 1993;81:2566-71.
27. Ildstad ST, Wren SM, Bluestone JA, Barbieri SA, Stephany D, Sachs DH. Effect of selective T cell depletion of host and/or donor bone marrow on lymphopoietic repopulation, tolerance, and graft-vs-host disease in mixed allogeneic chimeras (B10 + B10.D2 → B10). J Immunol 1986;136:28-33.
28. + T cell in mixed allogeneic reconstitution (C57BL/10Sn + B10.D2/nSn → C57BL/10Sn). J Exp Med 1986;163:1343-8.